Dofetilide

Formula: C₁₉H₂₇N₃O₅S₂

Molecular weight: 441.56 g/mol

Therapeutic area: Antiarrhythmic, Indicated for the maintenance of normal sinus rhythm in patients with atrial fibrillation/atrial flutter of greater than one-week duration who have been converted to normal sinus rhythm

Monographs: USP

Regulatory filings: FDA approved

Manufactured in: US

* Monographs are available on request
† Other filings are available on request